Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicriviroc in Treatment-Naïve HIV
NCT00551018Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vicriviroc in human immunodeficiency virus infection (HIV), sponsored by Merck & Co.. Started Dec 2007; status: completed.
02
Drugs
vicriviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00551018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551018.